901 results Stibbe advises Palex Medical Stibbe is advising Palex Medical, a Spain-based company specialising in high value-added MedTech equipment and solutions, on its planned acquisition of Duomed, a fast-growing European MedTech distributor. Stibbe assists RhĂ´ne with its partnership with Orkla Stibbe assisted investment vehicles affiliated with RhĂ´ne Capital on a partnership with Orkla whereby RhĂ´ne acquired 40% of the shares in Orkla Food Ingredients (OFI). Dutch Supreme Court clarifies rules on the moment of default by operation of law: can the default be deferred following actions of the creditor? The Dutch Supreme Court rendered judgment on 12 April 2024 ECLI:NL:HR:2024:575, clarifying the moment at which a debtor is in default following non-performance. The Commissionâs âkillerâ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite. Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all? The Foreign Subsidies Regulationâs initial focus on China Although the text of the Foreign Subsidies Regulation is not aimed at specific countries, the European Commissionâs initial enforcement actions appear to be targeting Chinese subsidies. Netherlands Chapter in The Legal 500: Mergers & Acquisitions laws and regulations Heleen Kersten and Omar El Gachi contributed to The Legal 500: Mergers & Acquisitions laws and regulations in a Q&A chapter about the Netherlands. Listing Act: Expanded exemptions for managers to trade during closed periods In October 2024, the European Council adopted the EU Listing Act, a legislative package that includes changes to the Market Abuse Regulation. We discuss the expanded exemptions to the prohibition of PDMRs carrying out transactions during a closed period. Third time lucky: Intel wins loyalty rebate battle at EU top court The European Court of Justice has upheld the annulment of Intelâs EUR 1.06 billion fine for abuse of dominance. The judgment provides guidance on how to assess the anti-competitiveness of loyalty rebates. If you have nothing nice to sayâŚTeva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and âdivisional gamingâ to delay market entry and hinder the uptake of a competing drug. Asset intensive reinsurance agreements â new requirement to obtain DNBâs prior consent As of 1 January 2025, Dutch insurers must obtain the Dutch Central Bankâs prior consent before making any amendments to, or entering into an asset-intensive reinsurance agreement that allows the reinsurer to hold assets in a third country. No reduction order for Shell on appeal: what does this mean? Shell climate case on appeal: no CO2 reduction order. What does this mean for the future? And for other companies? EU Listing Act enters into force 4 December 2024 The EU Listing Act, which includes updates to the Prospectus Regulation, Market Abuse Regulation, Markets in Financial Instruments Regulation, and to the Markets in Financial Instruments Directive, has been published on 14 November 2024. Decree on tax classification of foreign entities published On 13 November, the Dutch government published a decree on the comparison of foreign entities which provides a framework for the tax classification of foreign entities as either transparent or non-transparent for Dutch tax purposes. Jan-Jaap Koningsveld strengthens TMT/IP practice Stibbe Amsterdam Stibbe Amsterdam is pleased to announce the expansion of its TMT/IP practice with the appointment of Jan-Jaap Koningsveld as counsel. Stibbe contributes to Chambers ESG Guide 2024 The year 2024 has been notable for developments in ESG. Climate cases, impactful new laws and regulations, and geopolitical developments have shaped â or will largely shape â companies' choices. Stibbe has been a key contributor to the Chambers ESG Guide. Stibbe recognised in the GRR 100 2024 Stibbe has been recognised in the 2024 edition of GRR 100 (Global Restructuring Review) as one of the worldâs leading law firms in the field of cross-border restructuring and insolvency proceedings. European Commissionâs infringement procedure against the Netherlands: review and evaluation of water permits required under the WFD This blog addresses the European Commission's infringement procedure against the Netherlands regarding the evaluation of water licences under the Water Framework Directive, the Dutch legislature's approach and the consequences for issued permits. Pagination Previous page Page 23 Current page 24 Page 25 Page 26 Next page
Stibbe advises Palex Medical Stibbe is advising Palex Medical, a Spain-based company specialising in high value-added MedTech equipment and solutions, on its planned acquisition of Duomed, a fast-growing European MedTech distributor.
Stibbe assists RhĂ´ne with its partnership with Orkla Stibbe assisted investment vehicles affiliated with RhĂ´ne Capital on a partnership with Orkla whereby RhĂ´ne acquired 40% of the shares in Orkla Food Ingredients (OFI).
Dutch Supreme Court clarifies rules on the moment of default by operation of law: can the default be deferred following actions of the creditor? The Dutch Supreme Court rendered judgment on 12 April 2024 ECLI:NL:HR:2024:575, clarifying the moment at which a debtor is in default following non-performance.
The Commissionâs âkillerâ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite.
Digital antitrust conduct: too elusive to catch? The ink on the Digital Market Act has barely dried, but fast-evolving digital developments already have competition authorities calling for new tools. Is Big Tech not kept in check by the DMA, the antitrust rules and the EU Merger Regulation after all?
The Foreign Subsidies Regulationâs initial focus on China Although the text of the Foreign Subsidies Regulation is not aimed at specific countries, the European Commissionâs initial enforcement actions appear to be targeting Chinese subsidies.
Netherlands Chapter in The Legal 500: Mergers & Acquisitions laws and regulations Heleen Kersten and Omar El Gachi contributed to The Legal 500: Mergers & Acquisitions laws and regulations in a Q&A chapter about the Netherlands.
Listing Act: Expanded exemptions for managers to trade during closed periods In October 2024, the European Council adopted the EU Listing Act, a legislative package that includes changes to the Market Abuse Regulation. We discuss the expanded exemptions to the prohibition of PDMRs carrying out transactions during a closed period.
Third time lucky: Intel wins loyalty rebate battle at EU top court The European Court of Justice has upheld the annulment of Intelâs EUR 1.06 billion fine for abuse of dominance. The judgment provides guidance on how to assess the anti-competitiveness of loyalty rebates.
If you have nothing nice to sayâŚTeva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and âdivisional gamingâ to delay market entry and hinder the uptake of a competing drug.
Asset intensive reinsurance agreements â new requirement to obtain DNBâs prior consent As of 1 January 2025, Dutch insurers must obtain the Dutch Central Bankâs prior consent before making any amendments to, or entering into an asset-intensive reinsurance agreement that allows the reinsurer to hold assets in a third country.
No reduction order for Shell on appeal: what does this mean? Shell climate case on appeal: no CO2 reduction order. What does this mean for the future? And for other companies?
EU Listing Act enters into force 4 December 2024 The EU Listing Act, which includes updates to the Prospectus Regulation, Market Abuse Regulation, Markets in Financial Instruments Regulation, and to the Markets in Financial Instruments Directive, has been published on 14 November 2024.
Decree on tax classification of foreign entities published On 13 November, the Dutch government published a decree on the comparison of foreign entities which provides a framework for the tax classification of foreign entities as either transparent or non-transparent for Dutch tax purposes.
Jan-Jaap Koningsveld strengthens TMT/IP practice Stibbe Amsterdam Stibbe Amsterdam is pleased to announce the expansion of its TMT/IP practice with the appointment of Jan-Jaap Koningsveld as counsel.
Stibbe contributes to Chambers ESG Guide 2024 The year 2024 has been notable for developments in ESG. Climate cases, impactful new laws and regulations, and geopolitical developments have shaped â or will largely shape â companies' choices. Stibbe has been a key contributor to the Chambers ESG Guide.
Stibbe recognised in the GRR 100 2024 Stibbe has been recognised in the 2024 edition of GRR 100 (Global Restructuring Review) as one of the worldâs leading law firms in the field of cross-border restructuring and insolvency proceedings.
European Commissionâs infringement procedure against the Netherlands: review and evaluation of water permits required under the WFD This blog addresses the European Commission's infringement procedure against the Netherlands regarding the evaluation of water licences under the Water Framework Directive, the Dutch legislature's approach and the consequences for issued permits.